Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Puma Biotechnology Inc - Common Stock
(NQ:
PBYI
)
4.890
+0.050 (+1.03%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
421,941
Open
4.850
Bid (Size)
4.500 (200)
Ask (Size)
5.570 (200)
Prev. Close
4.840
Today's Range
4.850 - 5.030
52wk Range
2.575 - 6.120
Shares Outstanding
47,509,765
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 10, 2025
Via
Benzinga
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
November 07, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Performance
YTD
+56.7%
+56.7%
1 Month
-3.0%
-3.0%
3 Month
-2.0%
-2.0%
6 Month
+42.2%
+42.2%
1 Year
+63.0%
+63.0%
More News
Read More
Puma Biotechnology (NASDAQ:PBYI) Tops Q3 2025 Estimates and Raises Full-Year Outlook
↗
November 06, 2025
Via
Chartmill
Topics
Earnings
Puma Biotechnology Reports Third Quarter 2025 Financial Results
November 06, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
October 23, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma (PBYI) Q2 Revenue Rises 11%
↗
August 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Puma Biotechnology Reports Second Quarter Financial Results
August 07, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results
July 24, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports First Quarter Financial Results
May 08, 2025
From
Puma Biotechnology, Inc..
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
April 28, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
April 24, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
March 26, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
March 05, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Frequently Asked Questions
Is Puma Biotechnology Inc - Common Stock publicly traded?
Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
What exchange does Puma Biotechnology Inc - Common Stock trade on?
Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
What is the current price of Puma Biotechnology Inc - Common Stock?
The current price of Puma Biotechnology Inc - Common Stock is 4.890
When was Puma Biotechnology Inc - Common Stock last traded?
The last trade of Puma Biotechnology Inc - Common Stock was at 11/21/25 04:00 PM ET
What is the market capitalization of Puma Biotechnology Inc - Common Stock?
The market capitalization of Puma Biotechnology Inc - Common Stock is 232.32M
How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
Puma Biotechnology Inc - Common Stock has 232M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.